Please select the option that best describes you:
What adjuvant treatment would you recommend for stage III colon cancer in a patient >75yo but with a good performance status?
Since some prior subset analyses have suggested that oxaliplatin may not improve outcomes of older patients with colon cancer in the adjuvant setting, how do you approach this decision in older patients who are fit?
Answer from: Medical Oncologist at Academic Institution
As is often the case, I'd have to say "it depends". If the patient had stage IIIA disease for which the survival curves are better than IIB and comparable to IIA patients, I'd be inclined to offer capecitabine alone (providing no other poor risk factors such as insufficient nodal count, poorly...
Sign in or Register to read more